Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

<The fact that they remain as BoD members proves that they do NOT understand their limitations, >

You apparently are unwilling to accept as fact, that the strategy initiated by Phol and continued through RG was flawed from the beginning. We never really had the money or the talent to execute such a strategy sucessfully. I think/hope the BOD is acknowledging that. To me, that acknowledgement is more important than who sits on the board. I certainly would not want some new BOD thinking they can come in, buy a few start ups on the cheap and make them profitable over night.

The fact that you see a new BOD as necessary, suggests you still want PTSC to follow the umbrella strategy? If not that strategy, then what? What kind of expertise is needed etc...

Opty

Share
New Message
Please login to post a reply